FDA approves Syndax’s Revuforj to treat leukaemia
The approval marks the therapy as the first and only menin inhibitor for treating patients one year and older with relapsed or refractory acute leukaemia
The approval marks the therapy as the first and only menin inhibitor for treating patients one year and older with relapsed or refractory acute leukaemia
On November 16, during the American Heart Association (AHA) 2024 Annual Scientific Sessions in Chicago, IL, US, findings from the Phase III PALISADE (NCT05089084) clinical
CHICAGO — In his presidential address to the American Heart Association on Sunday, Keith Churchwell, a clinical cardiologist and past hospital administrator, started right at
Cancer cases are on the rise among people under 50 — and researchers aren’t sure why. A recent study by the American Cancer Society found
Republicans have despised the Affordable Care Act since its inception almost 15 years ago. But some health care executives think Republicans may actually help the
Nothing brought Olivia more joy than when her daughter and grandchild visited her group home in Brooklyn in the early 2000s. Each hug and shared
On November 16, at the American Heart Association (AHA) 2024 Annual Scientific Sessions in Chicago, IL, US, clinical trial results were presented from the ongoing
Opdivo and Yervoy combination is used for the first-line treatment of adult patients with colorectal cancer. Credit: Jo Panuwat D/Shutterstock. The European Medicines Agency’s (EMA)
Dr. Francesco Pompei, CEO and Founder of Exergen Corporation Accurate and frequent temperature monitoring is paramount when it comes to ensuring favorable patient outcomes in
Kamal Sharma, Project Manager at OmniMD The integration of Electronic Health Records (EHR) systems within healthcare organizations has revolutionized patient engagement. With the rise of